EarningsQ3 2025 Earnings Report

Santen Pharmaceutical Co (4536N) Q3 2025 Earnings Report

0 Followers

MX:4536N Q3 2025 EPS Results

Actual EPS$2.91

Consensus EPS$3.49

Beat/MissMissed by -$0.58

One Year Ago EPS$3.02

Actual Revenue$8.69B

Expected Revenue$9.02B

Beat/MissMissed by -$333.51M

YoY Revenue Growth-4.56%

QuarterQ3 2025

Date02/05/2026

TimeTBA

Conference CallThursday, February 5, 2026

MX:4536N Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:4536N Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q2)	3.72 / -	2.914	―
Aug 06, 2026	2026 (Q1)	2.54 / 2.67	2.065	29.21% (+0.60)
May 12, 2026	2025 (Q4)	3.67 / 5.71	3.072	85.80% (+2.64)
Feb 05, 2026	2025 (Q3)	3.49 / 2.91	3.02	-3.67% (-0.11)
Nov 06, 2025	2025 (Q2)	2.49 / 2.91	2.777	4.94% (+0.14)
Aug 07, 2025	2025 (Q1)	2.85 / 2.06	3.528	-41.47% (-1.46)
May 13, 2025	2024 (Q4)	2.06 / 3.07	1.953	57.30% (+1.12)
Feb 06, 2025	2024 (Q3)	3.11 / 3.02	2.408	25.40% (+0.61)
Nov 07, 2024	2024 (Q2)	2.59 / 2.78	2.877	-3.48% (-0.10)
Aug 06, 2024	2024 (Q1)	3.10 / 3.53	3.33	5.94% (+0.20)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed